<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN"
        "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180101.dtd">
<PubmedArticleSet>
    <PubmedArticle>
        <MedlineCitation Status="MEDLINE">
            <PMID Version="1">7914452</PMID>
            <DateCompleted>
                <Year>1994</Year>
                <Month>09</Month>
                <Day>12</Day>
            </DateCompleted>
            <DateRevised>
                <Year>2007</Year>
                <Month>11</Month>
                <Day>14</Day>
            </DateRevised>
            <Article PubModel="Print">
                <Journal>
                    <ISSN IssnType="Print">1061-4036</ISSN>
                    <JournalIssue CitedMedium="Print">
                        <Volume>6</Volume>
                        <Issue>4</Issue>
                        <PubDate>
                            <Year>1994</Year>
                            <Month>Apr</Month>
                        </PubDate>
                    </JournalIssue>
                    <Title>Nature genetics</Title>
                    <ISOAbbreviation>Nat. Genet.</ISOAbbreviation>
                </Journal>
                <ArticleTitle>Ceruloplasmin gene defect associated with epilepsy in EL mice.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>426-31</MedlinePgn>
                </Pagination>
                <Abstract>
                    <AbstractText>Epilepsy is a dominant trait in EL mice, a model for human complex partial seizures.
                        We recently mapped the major gene, El-1, to chromosome 9 near the predicted location for the
                        ceruloplasmin (Cp) gene. We now present evidence for a partial duplication in the Cp gene in EL
                        mice. This Cp duplication is coinherited with seizures in backcross generations and is
                        associated with enhanced expression of Cp mRNA and increased Cp oxidase activity. Moreover, the
                        duplication is associated with an enhanced frequency of double recombinants, simulating negative
                        interference. The findings are relevant to the basic mechanisms of epilepsy and to theories of
                        genetic recombination and gene mapping.
                    </AbstractText>
                </Abstract>
                <AuthorList>
                    <Author>
                        <LastName>Garey</LastName>
                        <ForeName>C E</ForeName>
                        <Initials>CE</Initials>
                        <AffiliationInfo>
                            <Affiliation>Department of Biology, Boston College, Chestnut Hill, Massachusetts 02167.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author>
                        <LastName>Schwarzman</LastName>
                        <ForeName>A L</ForeName>
                        <Initials>AL</Initials>
                        <AffiliationInfo>
                            <Affiliation>Department of Biology, Boston College, Chestnut Hill, Massachusetts 02167.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author>
                        <LastName>Rise</LastName>
                        <ForeName>M L</ForeName>
                        <Initials>ML</Initials>
                        <AffiliationInfo>
                            <Affiliation>Department of Biology, Boston College, Chestnut Hill, Massachusetts 02167.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author>
                        <LastName>Seyfried</LastName>
                        <ForeName>T N</ForeName>
                        <Initials>TN</Initials>
                        <AffiliationInfo>
                            <Affiliation>Department of Biology, Boston College, Chestnut Hill, Massachusetts 02167.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <GrantList>
                    <Grant>
                        <GrantID>NS 23355</GrantID>
                        <Acronym>NS</Acronym>
                        <Agency>NINDS NIH HHS</Agency>
                        <Country>United States</Country>
                    </Grant>
                </GrantList>
                <PublicationTypeList>
                    <PublicationType UI="D016428">Journal Article</PublicationType>
                    <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                    <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
                    <PublicationType UI="D016441">Retracted Publication</PublicationType>
                </PublicationTypeList>
            </Article>
            <MedlineJournalInfo>
                <Country>UNITED STATES</Country>
                <MedlineTA>Nat Genet</MedlineTA>
                <NlmUniqueID>9216904</NlmUniqueID>
                <ISSNLinking>1061-4036</ISSNLinking>
            </MedlineJournalInfo>
            <ChemicalList>
                <Chemical>
                    <RegistryNumber>0</RegistryNumber>
                    <NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance>
                </Chemical>
                <Chemical>
                    <RegistryNumber>789U1901C5</RegistryNumber>
                    <NameOfSubstance UI="D003300">Copper</NameOfSubstance>
                </Chemical>
                <Chemical>
                    <RegistryNumber>EC 1.16.3.1</RegistryNumber>
                    <NameOfSubstance UI="D002570">Ceruloplasmin</NameOfSubstance>
                </Chemical>
            </ChemicalList>
            <CitationSubset>IM</CitationSubset>
            <CommentsCorrectionsList>
                <CommentsCorrections RefType="CommentIn">
                    <RefSource>NIH Guide Grants Contracts. 2000 Oct 10;:OD-01-002</RefSource>
                    <PMID Version="1">12458559</PMID>
                </CommentsCorrections>
                <CommentsCorrections RefType="RetractionIn">
                    <RefSource>Garey CE, Schwarzman AL, Rise ML, Seyfried TN. Nat Genet. 1995 Sep;11(1):104</RefSource>
                    <PMID Version="1">7550304</PMID>
                </CommentsCorrections>
            </CommentsCorrectionsList>
            <GeneSymbolList>
                <GeneSymbol>Cp</GeneSymbol>
                <GeneSymbol>El-1</GeneSymbol>
            </GeneSymbolList>
            <MeshHeadingList>
                <MeshHeading>
                    <DescriptorName UI="D000818">Animals</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D002570">Ceruloplasmin</DescriptorName>
                    <QualifierName UI="Q000096">biosynthesis</QualifierName>
                    <QualifierName MajorTopicYN="Y" UI="D005823">genetics</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D002874">Chromosome Mapping</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D003300">Copper</DescriptorName>
                    <QualifierName UI="D010827">physiology</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D003433">Crosses, Genetic</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D003434">Crossing Over, Genetic</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName MajorTopicYN="Y" UI="D004195">Disease Models, Animal</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D017029">Epilepsy, Complex Partial</DescriptorName>
                    <QualifierName UI="Q000201">enzymology</QualifierName>
                    <QualifierName MajorTopicYN="Y" UI="D005823">genetics</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D015971">Gene Expression Regulation, Enzymologic</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D006801">Humans</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D008099">Liver</DescriptorName>
                    <QualifierName UI="Q000201">enzymology</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D051379">Mice</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D008810">Mice, Inbred C57BL</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D008811">Mice, Inbred DBA</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D008815">Mice, Inbred Strains</DescriptorName>
                    <QualifierName MajorTopicYN="Y" UI="D005823">genetics</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D008818">Mice, Neurologic Mutants</DescriptorName>
                    <QualifierName MajorTopicYN="Y" UI="D005823">genetics</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName MajorTopicYN="Y" UI="D005810">Multigene Family</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D009419">Nerve Tissue Proteins</DescriptorName>
                    <QualifierName UI="Q000096">biosynthesis</QualifierName>
                    <QualifierName UI="D005823">genetics</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D016133">Polymerase Chain Reaction</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D012150">Polymorphism, Restriction Fragment Length</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D011995">Recombination, Genetic</DescriptorName>
                </MeshHeading>
            </MeshHeadingList>
        </MedlineCitation>
        <PubmedData>
            <History>
                <PubMedPubDate PubStatus="pubmed">
                    <Year>1994</Year>
                    <Month>4</Month>
                    <Day>1</Day>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="medline">
                    <Year>1994</Year>
                    <Month>4</Month>
                    <Day>1</Day>
                    <Hour>0</Hour>
                    <Minute>1</Minute>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="entrez">
                    <Year>1994</Year>
                    <Month>4</Month>
                    <Day>1</Day>
                    <Hour>0</Hour>
                    <Minute>0</Minute>
                </PubMedPubDate>
            </History>
            <PublicationStatus>ppublish</PublicationStatus>
            <ArticleIdList>
                <ArticleId>7914452</ArticleId>
                <ArticleId IdType="doi">10.1038/ng0494-426</ArticleId>
            </ArticleIdList>
        </PubmedData>
    </PubmedArticle>
</PubmedArticleSet>

